Peregrine Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
2025
Q2
$14.8K Sell
2025
Q1
$4.4M Buy
2024
Q4
$6.54M Buy
2024
Q3
$5.23M Buy
2024
Q2
$5.73M Buy
2024
Q1
$4.6M Sell
2023
Q4
$3.71M Sell
2023
Q3
$5.48M Buy
2023
Q2
$4.58M Sell
2023
Q1
$9.73M Buy
2022
Q4
$8.42M Sell
2022
Q3
$8.22M Sell
2022
Q2
$7.21M Sell
2022
Q1
$7.52M Buy